Suppr超能文献

智障人士药物评价中常见疾病及非处方药的描述。

Description of Common Ailments and Nonprescription Medications Found in Medication Reviews for People With Intellectual Disability.

作者信息

Felkai Chelsea, Carew Jamie-Lee, Newby David, Croft Hayley

机构信息

School of Biomedical Sciences and Pharmacy, College of Health Medicine and Wellbeing, The University of Newcastle, Callaghan, New South Wales, Australia.

出版信息

J Intellect Disabil Res. 2025 Jul;69(7):613-620. doi: 10.1111/jir.13243. Epub 2025 Apr 24.

Abstract

BACKGROUND

People with intellectual disability (ID) are more susceptible to experiencing minor health issues. This research describes the common ailments and nonprescription medications found in people with ID who have had a medication review performed by a credentialed pharmacist in Australia.

AIMS

The aims of this research were to (i) describe the common ailments found within people with ID and (ii) identify and quantify the nonprescription medications documented in medication reviews for people with ID.

METHOD

This research conducted a retrospective analysis of medication review reports and referrals from credentialed pharmacists who have performed a medication review for a person with ID between January 2020 and January 2024.

RESULTS

A total of 80 responses and reports were obtained. The average age of the person with ID was 52 years. On average, each medication review listed 6.6 common ailments and 8.0 nonprescription medications. The highest number of nonprescription medications listed for a single individual was 26.

CONCLUSION

This research is the first to exclusively examine common ailments and nonprescription medications found in people with ID through medication reviews. Further research is needed to confirm study findings revealing a potentially high occurrence of common ailments and nonprescription medication use in this population compared to other similar populations and notable polypharmacy for nonprescription medications.

摘要

背景

智力残疾(ID)患者更容易出现轻微健康问题。本研究描述了在澳大利亚接受过有资质药剂师进行药物审查的ID患者中发现的常见疾病和非处方药物。

目的

本研究的目的是(i)描述ID患者中发现的常见疾病,以及(ii)识别并量化ID患者药物审查中记录的非处方药物。

方法

本研究对2020年1月至2024年1月期间为ID患者进行过药物审查的有资质药剂师的药物审查报告和转诊进行了回顾性分析。

结果

共获得80份回复和报告。ID患者的平均年龄为52岁。平均而言,每份药物审查列出了6.6种常见疾病和8.0种非处方药物。单个个体列出的非处方药物数量最多为26种。

结论

本研究首次通过药物审查专门研究了ID患者中发现的常见疾病和非处方药物。需要进一步的研究来证实研究结果,即与其他类似人群相比,该人群中常见疾病和非处方药物使用的发生率可能较高,且非处方药物存在明显的多药联用情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d75/12198093/400335d3af16/JIR-69-613-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验